Your browser doesn't support javascript.
loading
BRPF1-associated intellectual disability, ptosis, and facial dysmorphism in a multiplex family.
Pode-Shakked, Naomi; Barel, Ortal; Pode-Shakked, Ben; Eliyahu, Aviva; Singer, Amihood; Nayshool, Omri; Kol, Nitzan; Raas-Rothschild, Annick; Pras, Elon; Shohat, Mordechai.
Afiliação
  • Pode-Shakked N; Department of Pediatrics A, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
  • Barel O; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel.
  • Pode-Shakked B; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Eliyahu A; The Genomic Unit, Sheba Cancer Research Center, Sheba Medical Center, Tel-Hashomer, Israel.
  • Singer A; The Dr. Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Center, Tel-Hashomer, Israel.
  • Nayshool O; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Kol N; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel-Hashomer, Israel.
  • Raas-Rothschild A; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Pras E; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Tel-Hashomer, Israel.
  • Shohat M; Community Genetics, Public Health Services, Ministry of Health, Jerusalem, Israel.
Mol Genet Genomic Med ; 7(6): e665, 2019 06.
Article em En | MEDLINE | ID: mdl-31020800
ABSTRACT

BACKGROUND:

Over 500 epigenetic regulators have been identified throughout the human genome. Of these, approximately 30 chromatin modifiers have been implicated thus far in human disease. Recently, variants in BRPF1, encoding a chromatin reader, have been associated with a previously unrecognized autosomal dominant syndrome manifesting with intellectual disability (ID), hypotonia, dysmorphic facial features, ptosis, and/or blepharophimosis in 22 individuals. PATIENTS AND

METHODS:

We report a multiply affected nonconsanguineous family of mixed Jewish descent who presented due to ID in three male siblings. Molecular analysis of the family was pursued using whole exome sequencing (WES) and subsequent Sanger sequencing.

RESULTS:

Whole exome sequencing analysis brought to the identification of a novel heterozygous truncating mutation (c.556C>T, p.Q186*) in the BRPF1 gene in the affected siblings and their mother. The four affected individuals showed varying degrees of intellectual disability, distinct facial features including downslanted palpebral fissures, ptosis, and/or blepharophimosis. Their clinical characteristics are discussed in the context of previously reported patients with the BRPF1-related phenotype.

CONCLUSION:

The reported family contributes to the current knowledge regarding this unique and newly recognized genetic disorder, and further implicates the role of BRPF1 in human brain development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Proteínas de Ligação a DNA / Deficiência Intelectual Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Adaptadoras de Transdução de Sinal / Proteínas de Ligação a DNA / Deficiência Intelectual Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Mol Genet Genomic Med Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Israel